Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide-induced sepsis.
<h4>Background</h4>Cell-based therapies with bone marrow-derived progenitor cells (BMDPC) lead to an improved clinical outcome in animal sepsis models. In the present study we evaluated the ability of granulocyte macrophage-colony stimulating factor (GM-CSF) to mobilize BMDPC in a lipopo...
Main Authors: | Jörg Krebs, Alexander Hillenbrand, Charalambos Tsagogiorgas, Christian Patry, Burkhard Tönshoff, Benito Yard, Grietje Beck, Neysan Rafat |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0218602 |
Similar Items
-
VCAM-1 expression is upregulated by CD34+/CD133+-stem cells derived from septic patients.
by: Christian Patry, et al.
Published: (2018-01-01) -
CXCR-4 expression by circulating endothelial progenitor cells and SDF-1 serum levels are elevated in septic patients
by: Christian Patry, et al.
Published: (2018-05-01) -
Endothelial Progenitor and Mesenchymal Stromal Cells in Newborns With Congenital Diaphragmatic Hernia Undergoing Extracorporeal Membrane Oxygenation
by: Neysan Rafat, et al.
Published: (2019-11-01) -
The Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Neutropenia and Mortality in Neonatal Sepsis
by: Syed Arsalan Hassan, et al.
Published: (2023-12-01) -
Impact of different emulsifiers on biocompatibility and inflammatory potential of Perfluorohexyloctane (F6H8) emulsions for new intravenous drug delivery systems
by: Tsagogiorgas C, et al.
Published: (2019-06-01)